conflict-of-interest
27 stories tagged "conflict-of-interest"
Men Who Iced After Lifting Gained a Third of the Thigh Muscle Their Peers Did
Twelve weeks of cold water after leg day left men with 103 grams of new quadriceps muscle against 309 for those who cycled, and most of the recovery aisle is sold on soreness, not gains.
Drugs & FDAKennedy's Peptide Plan Reaches the White House, and Wall Street Is Already Counting the Money
Peptides already sell on a Queens bodega shelf, so moving them into licensed pharmacies is progress. Whether it protects anyone depends on one missing rule: test each lot and report every injury.
Autoimmune & InflammationNovo Nordisk Paid to Count the Inflamed Heart Failure Patients Its Antibody Is Chasing
Three big studies putting heart failure inflammation anywhere from 38% to more than half were funded by Novo Nordisk, whose IL-6 antibody missed its first outcomes trial in July. Their predictor tables point at fat, smoking and kidneys.
Drugs & FDAA Heart-Failure Implant Won by 40 Points on a Questionnaire Filled Out by Patients Who Knew Which Arm They Were In
Patients given Berlin Heals' microcurrent implant reported quality-of-life gains eight times the control arm's in an open-label trial. The blood marker and exercise test that could have backed them up showed no significant difference, and the company paid for the study.
InvestigationsThe FDA Is Recruiting New Advisers Without Publishing the Rule for Who's Too Conflicted to Sit
Acting commissioner Kyle Diamantas is inviting scientists and 'consumer voices' onto the FDA's advisory panels. The agency has never published how it decides which of them carries a disqualifying conflict, thirteen years after Congress ordered it to.
InvestigationsThe MAHA Summit Charged Corporations Up to $300,000 for a Seat Beside the Officials Who Regulate Them
UnitedHealth got a panel. Grail, whose cancer test sat before the FDA, helped foot the bill. The regenerative ranchers and pesticide experts were nowhere on the program.
CancerA 34-Year Mammography Advocate Co-Wrote the Study That Shrinks Screening's Biggest Harm
Overdiagnosis, the risk that screening treats cancers that never would have killed you, was pegged as high as 50 percent. A reinterpretation of eight old trials now puts it under 5, with an author who has promoted screening for 34 years.
Metabolic & WeightOne in Six Kids on Weight-Loss Drugs Was Diagnosed With a Nutrient Deficiency, and Only 5 Percent Got Nutrition Counseling
The alarm about kids going short on vitamin D on Ozempic-style drugs came from a study funded by Abbott, which sells the very nutrition drinks marketed to fill those gaps.
CancerThe Compound That Outsmarts Cancer's Defenses: Eight Cell Lines, a Few Mice, and a Startup
Baylor researchers say CS18 dismantles the survival switch tumors use to resist treatment. It works in eight cell lines and a handful of mice, and its inventors just incorporated a company around it.
CancerThe Mesothelioma Drug in This Month's Headlines Was Tested in Fifteen People
The scientist whose lab found the drug's target is also chief science officer of the company selling it, a conflict the breakthrough headlines tuck into a job title.
Autoimmune & InflammationSeven Biologics, Up to $47,000 a Year, and 89 Percent of Europe's Severe Asthmatics Still Aren't in Remission
The Lancet calls severe asthma an 'unmet need.' A 13,455-patient European registry shows most of those patients are already on the pricey biologics, and 89 percent still have active disease.
CancerThe Study Breaking Pancreatic Cancer's 'Shield' Was Co-Written by the Drug's Maker
The 'breakthrough' bought engineered mice eleven extra days, its headline human numbers come from a post-hoc subgroup, and one author is the chief scientist of the company that makes the drug.
InvestigationsThe Zombie Papers: Retracted Stem-Cell Studies Still Feeding the Unproven-Cure Marketplace
A stem-cell paper retracted in November 2021 kept collecting citations for years, 72 by mid-2026, 27 of them after the notice went up, 15 since 2023 that never mention it. Two researchers counted, and named who is supposed to be cleaning up.
InvestigationsA Journal Built to Critique Capitalism Sold for €360,000. Its Fifteen Editors Read the New Fees and Quit.
A €360,000 sale, a €1,350 charge to publish, and a 25 percent fee to withdraw your own paper: the board of a journal built to critique capitalism read the new terms and resigned en masse.
Metabolic & WeightEurope Wants Every Heart Patient Tested for Kidney Disease. The Test Is Cheap. The Drugs It Funnels You Toward Are Not.
The European Society of Cardiology now says screen every heart patient for kidney damage and start the drugs early. More than 80 percent of the guideline's authors report financial ties to industry.
CancerTwenty People, No Control Arm, and a Startup on the Side: Reading the Pancreatic Cancer Vaccine's Fine Print
Ninety percent of twenty volunteers made KRAS-specific T cells. None was shown to avoid cancer. Two of the investigators co-founded the company that licensed the shot from Johns Hopkins, which stands to collect royalties.
Nutrition & FoodA PETA-Tied Doctors Group Is Suing to Kill RFK Jr.'s New Food Pyramid
The Physicians Committee says a secret, industry-tied panel redirected the 2025-2030 dietary guidelines. The group crying capture spent years inside PETA's funding orbit.
CancerUC Irvine's 'Framework' for Safer CAR-T Is a Hypothesis Essay, Not a Study
The senior author consults for Kite Pharma, whose Yescarta accounted for all 6 grade-5 neurotoxicity deaths in the cited review's real-world data, the exact harm the paper proposes to treat.
Infectious DiseaseEight Infant Macaques Showed No HIV Rebound for a Year. The Third Drug Comes From a Convicted-Fraud Biotech.
OHSU's triple regimen left no detectable virus in all eight infant macaques a year after treatment stopped, even after the harshest rebound test. Two of the authors hold a financial stake in the company behind the experimental third drug.
InvestigationsA JAMA Essay Says the Doctor Makes Your Care Worse. Three of Its Four Authors Sell the AI.
The Viewpoint predicts autonomous AI will run much of primary care by 2030, and that adding a human doctor can make the care worse. Its evidence is trained actors chatting over text, and three of its four authors sell or bankroll the AI.
Nutrition & FoodThe Study Telling You Not to Bother Cutting Sweet Foods Was Co-Funded by the Soda and Sweetener Industry
The Sweet Tooth Trial found no reason to reduce sweet-tasting foods. Its private funders include the soda industry's trade group and the International Sweeteners Association.
InvestigationsTwo Scientists Nominated Fauci for Cash Prizes. Then His Agency Funded Them by the Hundreds of Millions.
The emails Rand Paul released July 24 show Fauci's taxpayer-funded staff drafting his award nominations, and two scientists who submitted them going on to draw large NIAID grants.
Brain & AgingA Juice Company Built a Department Inside a Japanese University. Its Scientists Just Found Vitamin C Guards the Aging Brain.
Kagome, Japan's largest vegetable-juice maker, funded the work, employs two of its authors, and measured the vitamin itself. The gray-matter correlation it reported is real, and small enough to miss.
Nutrition & FoodSummer Sun Won't Save You: A Vitamin D Study Funded by the People Who Sell the Spray
A Newcastle screening study found vitamin D deficiency persists through summer in older and ethnic-minority adults in northern Britain. The funder sells the fix.